Hypotensive pharmaceutical composition comprising triple activator having activity for all of glucagon, glp-1, and gip receptors
US-2024024426-A1 · Jan 25, 2024 · US
Hanmi Pharm Ind Co Ltd patents
Hanmi Pharm Ind Co Ltd holds 265 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 265 |
| Recent patents | 34 |
| First publication | Apr 9, 2015 |
| Latest publication | Jan 25, 2024 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Novel conjugate of immune-stimulating il-2 analog and preparation method thereof
US-2024009317-A1 · Jan 11, 2024 · US
Use of therapeutic enzyme fusion protein in prevention and treatment of neuropathy caused by or accompanied by fabry disease
US-2023416714-A1 · Dec 28, 2023 · US
Use of therapeutic enzyme fusion protein in prevention and treatment of renal diseases caused by or accompanied by fabry disease
US-2023405093-A1 · Dec 21, 2023 · US
Use of trigonal agonist having activities to all of glucagon, glp-1, and gip receptors in treatment of sequelae following respiratory infectious diseases
US-2023390362-A1 · Dec 7, 2023 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Hypotensive pharmaceutical composition comprising triple activator having activity for all of glucagon, glp-1, and gip receptors
US-2024024426-A1 · Jan 25, 2024 · US
Novel conjugate of immune-stimulating il-2 analog and preparation method thereof
US-2024009317-A1 · Jan 11, 2024 · US
Use of therapeutic enzyme fusion protein in prevention and treatment of neuropathy caused by or accompanied by fabry disease
US-2023416714-A1 · Dec 28, 2023 · US
Use of therapeutic enzyme fusion protein in prevention and treatment of renal diseases caused by or accompanied by fabry disease
US-2023405093-A1 · Dec 21, 2023 · US
Use of trigonal agonist having activities to all of glucagon, glp-1, and gip receptors in treatment of sequelae following respiratory infectious diseases
US-2023390362-A1 · Dec 7, 2023 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 253 |
| Chemistry & Metallurgy | 200 |
| Operations & Transport | 6 |
| Physics | 5 |
| Cross-Sectional Technologies | 3 |
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Hanmi Pharm Ind Co Ltd have in patentsdb?
- Hanmi Pharm Ind Co Ltd is linked to 265 publications as assignee in our database.
- What technology areas does Hanmi Pharm Ind Co Ltd patent most?
- Top mapped technology areas by patent count: Human Necessities (253); Chemistry & Metallurgy (200); Operations & Transport (6).
- Is Hanmi Pharm Ind Co Ltd's patent activity growing?
- In our data, assignee counts were 48 in 2023 and 2 in 2024 (lower year over year).
- What are recent patents assigned to Hanmi Pharm Ind Co Ltd?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.